Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection
Md S. Bhuiyan, Ben J. Brintz, View ORCID ProfileAlana L. Whitcombe, Alena J. Markmann, Luther A. Bartelt, View ORCID ProfileNicole J. Moreland, Andrew S. Azman, View ORCID ProfileDaniel T. Leung
doi: https://doi.org/10.1101/2021.09.06.21261175
Md S. Bhuiyan
1Division of Infectious Disease, University of Utah School of Medicine, Salt Lake City, Utah, USA
Ben J. Brintz
2Division of Epidemiology, University of Utah School of Medicine, Salt Lake City, Utah, USA
Alana L. Whitcombe
3Faculty of Medical and Health Sciences, University of Auckland, New Zealand
4Maurice Wilkins Center, University of Auckland, New Zealand
Alena J. Markmann
5Department of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Luther A. Bartelt
5Department of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill NC 27599, USA
Nicole J. Moreland
3Faculty of Medical and Health Sciences, University of Auckland, New Zealand
4Maurice Wilkins Center, University of Auckland, New Zealand
Andrew S. Azman
6Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
7Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Daniel T. Leung
1Division of Infectious Disease, University of Utah School of Medicine, Salt Lake City, Utah, USA
8Division of Microbiology & Immunology, University of Utah School of Medicine, Salt Lake City, Utah, USA
Data Availability
All code and data will be deposited on github upon publication.
Posted September 08, 2021.
Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection
Md S. Bhuiyan, Ben J. Brintz, Alana L. Whitcombe, Alena J. Markmann, Luther A. Bartelt, Nicole J. Moreland, Andrew S. Azman, Daniel T. Leung
medRxiv 2021.09.06.21261175; doi: https://doi.org/10.1101/2021.09.06.21261175
Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection
Md S. Bhuiyan, Ben J. Brintz, Alana L. Whitcombe, Alena J. Markmann, Luther A. Bartelt, Nicole J. Moreland, Andrew S. Azman, Daniel T. Leung
medRxiv 2021.09.06.21261175; doi: https://doi.org/10.1101/2021.09.06.21261175
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2841)
- Dermatology (243)
- Emergency Medicine (428)
- Epidemiology (12551)
- Forensic Medicine (10)
- Gastroenterology (803)
- Genetic and Genomic Medicine (4425)
- Geriatric Medicine (401)
- Health Economics (715)
- Health Informatics (2849)
- Health Policy (1047)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4184)
- Nursing (222)
- Nutrition (617)
- Oncology (2200)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (267)
- Palliative Medicine (81)
- Pathology (486)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6775)
- Radiology and Imaging (1487)
- Respiratory Medicine (899)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (174)